2 Predictions for Novo Nordisk in 2026

Can Novo Nordisk get its comeback going in 2026? Let's discuss two things that could materialize for the company next year ...
Welltica+ on MSN

GLP-1 drugs evaluated for potential impact on early Alzheimer’s

New findings from a major trial offer a clearer, more nuanced view of how GLP-1 medications may influence the course of ...

Ozempic Enters India: Diabetes Drug, Not A ‘Miracle Fix', Novo Nordisk MD to NDTV

Global diabetes drug Ozempic (semaglutide) has now been launched in India by Danish pharmaceutical major Novo Nordisk. In an ...
TheHealthSite

Ozempic Now In India: Who Should Avoid The Popular Type 2 Diabetes, Weight-Loss Drug

Danish Novo Nordisk launched its blockbuster treatment injection Ozempic in three forms in 0.25 mg, 0.5 mg and 1 mg in the ...
Medical Dialogues

Novo Nordisk Gets CDSCO Panel Nod to Update Wegovy Label With New Safety, Pharmacodynamics Data

The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has recommended granting approval to Novo Nordisk India for its proposed update to ...
Eastern Mirror

Weight-Loss Drug Ozempic Launched in India, Priced at INR 8,800 a Month

Novo Nordisk on Friday launched its blockbuster weight-loss drug Ozempic in India, beginning at INR 8,800 a month or four ...